The company, Marion Biotech, bought the ingredient propylene glycol (PG) from trader Maya Chemtech India, as reported by Reuters. But Maya did not have a licence to sell pharmaceutical-grade materials.
The WHO said this week that 21 batches of cough syrup made by India’s Marion Biotech Ltd. were tested by Uzbek authorities and found to contain unsafe levels of two toxins.